Financial News
Virios Therapeutics Inc (NQ: VIRI )
0.2492
-0.0158
(-5.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
All News about Virios Therapeutics Inc
![](https://mms.businesswire.com/media/20220317005051/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2838.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/earnings_image_733.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/ep_us_feature_image_1556.jpeg)
![](https://mms.businesswire.com/media/20220228005060/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/photo-1584036533827-45bce166ad94.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech2.jpg)
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/screenshot_2022-01-27_at_7.27.18_pm.png)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/13455.jpg?v=0)
RedChip Partners with Benzinga to Host Exclusive Small-Cap CEO Interview Series on January 28
January 26, 2022
From RedChip
Via AccessWire
![](https://mms.businesswire.com/media/20220104005698/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/analyst_ratings_image_4679.jpeg?width=720)
![](https://mms.businesswire.com/media/20211201005069/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20211111005226/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20211104005091/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_321.png)
![](https://mms.businesswire.com/media/20210908005139/en/1096317/4/Virios_Logo_Blue.jpg)
Virios Therapeutics Granted New Patent for Antiviral Inhibitor Combination
September 08, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210902005063/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210819005057/en/1096317/4/Virios_Logo_Blue.jpg)
Virios Therapeutics Announces New Social Media Profiles
August 19, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210816005040/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20210812005079/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/1815.jpg)
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
August 16, 2021
From Stock News Now
Via AccessWire
Topics
Cannabis
Exposures
Cannabis
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/dna-24559_1280_41.png)
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/earnings_scheduled_1921.png)
![](https://mms.businesswire.com/media/20210811005050/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20210809005065/en/1096317/4/Virios_Logo_Blue.jpg)
Virios Therapeutics Featured in Bloomberg TV Interview
August 09, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210805005073/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://mms.businesswire.com/media/20210726005178/en/1096317/4/Virios_Logo_Blue.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/virios_therapeutics.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.